课题基金 / 基金详情

Studies on the signal transduction of difrentiation inducing factor and an application for the development of anti-cancer drug for early G_1 phase.

Studies on the signal transduction of difrentiation inducing factor and an application for the development of anti-cancer drug for early G_1 phase.
分化诱导因子的信号转导研究及其在早期G_1期抗癌药物开发中的应用。
批准号:
14370034
负责人:
SASAGURI Toshiyuki
金额:
$6.72万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

SASAGURI Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Differentiation-inducing factors (DIFs) are morphogens which induce cell differentiation in Dictyostelium. However, the effect of the DIF family is not limited in Dictyostelium. DIF-1 and/or DIF-3 strongly inhibit cell proliferation and induce cell differentiation in several mammalian cells. We therefore investigated the mechanisms for the antiproliferative action of DIFs in mammalian cells.We found that DIFs (DIF-1 and DIF-3) activates GSK-3β to accelerate the proteolysis of cyclin D1 and this mechanism is involved in the DIFs-induced G_0/G_1 arrest in mammalian cells. We next examined the effect of DIFs on cyclin D1 mutants and found that the phosphorylation of Thr^<286> was critical for cyclin D1 degradation induced by DIFs. These findings suggest that DIF-1 induces degradation of cyclin D1 through the GSK-3β-mediated phosphorylation of Thr^<286>. Moreover, we tried to identify the mechanism for the DIF-1-induced suppression of cyclin D1 mRNA expression and found that DIF-1 induces GSK-3β-mediaged degradation of β-catenin, resulting in the suppression of TCF/LEF transcriptional activity in the cyclin D1 promoter.Further, we tried to identify a kinase which induce phosphorylation on Tyr^<216> in GSK-3β and suggested that MEK1/2 induces tyrosine phosphorylation of GSK-3β and this cellular event might induce nuclear translocation of GSK-3β.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1074/jbc.m205768200
发表时间: 2003-03-14
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Takahashi-Yanaga, F, Taba, Y, Sasaguri, T]
通讯作者: Sasaguri, T
Fumi Takahashi-Yanaga et al.: "Glycogen synthase kinase-3b is tyrosine phosphorylated by MEK1 in human skin fibroblasts"Biochem.Biophys.Res.Commun.. In press. (2004)
Fumi Takahashi-Yanaga 等人:“糖原合成酶激酶 3b 在人皮肤成纤维细胞中被 MEK1 酪氨酸磷酸化”Biochem.Biophys.Res.Commun.. 正在出版。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fumi Takahashi-Yanaga et al.: "Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells"J.Biol.Chem.. 278. 9663-9670 (2003)
Fumi Takahashi-Yanaga 等人:“盘基网柄菌分化诱导因子 3 激活糖原合酶激酶 3β 并降解哺乳动物细胞中的细胞周期蛋白 D1”J.Biol.Chem.. 278. 9663-9670 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fumi Takahashi-Yanaga et al.: "Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells"J. Biol. Chem.. (in press). (2003)
Fumi Takahashi-Yanaga 等人:“盘基网柄菌分化诱导因子 3 激活糖原合成酶激酶 3β 并降解哺乳动物细胞中的细胞周期蛋白 D1”J. Biol.(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of an inhibitor of mPGES-1 expression and its target molecule
  • 批准号:
    23659138
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2011
  • 负责人:
    SASAGURI Toshiyuki
  • 依托单位:
Pharmacogenetic studies on the influence of ALDH2 gene polymorphisms on the vasodilation induced by organic nitrates
  • 批准号:
    20390160
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.98万
  • 财政年份:
    2008
  • 负责人:
    SASAGURI Toshiyuki
  • 依托单位:
Linkage between G protein-coupled receptors and the Jak/STAT pathway in cardiovascular cells
Regulation of proliferatin in vascular endothelial and smooth muscle cells by the protein kinase C pathway
国内基金
海外基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
  • 批准号:
    82371223
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    闻大翔
  • 依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
  • 批准号:
    82373139
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李孟鸿
  • 依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
  • 批准号:
    82372089
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李万万
  • 依托单位: